Division of Neuropathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
PLoS One. 2011;6(5):e19629. doi: 10.1371/journal.pone.0019629. Epub 2011 May 13.
The expression of focal adhesion kinase family interacting protein of 200-kDa (FIP200) in normal brain is limited to some neurons and glial cells. On immunohistochemical analysis of biopsies of glioblastoma tumors, we detected FIP200 in the tumor cells, tumor-associated endothelial cells, and occasional glial cells. Human glioblastoma tumor cell lines and immortalized human astrocytes cultured in complete media also expressed FIP200 as did primary human brain microvessel endothelial cells (MvEC), which proliferate in culture and resemble reactive endothelial cells. Downregulation of endogenous expression of FIP200 using small interfering RNA resulted in induction of apoptosis in the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC. It has been shown by other investigators using cells from other tissues that FIP200 can interact directly with, and inhibit, proline-rich tyrosine kinase 2 (Pyk2) and focal adhesion kinase (FAK). In the human glioblastoma tumor cells, immortalized human astrocytes, and primary human brain MvEC, we found that downregulation of FIP200 increased the activity of Pyk2 without increasing its expression, but did not affect the activity or expression of FAK. Coimmunoprecipitation and colocalization studies indicated that the endogenous FIP200 was largely associated with Pyk2, rather than FAK, in the glioblastoma tumor cells and brain MvEC. Moreover, the pro-apoptotic effect of FIP200 downregulation was inhibited significantly by a TAT-Pyk2-fusion protein containing the Pyk2 autophosphorylation site in these cells. In summary, downregulation of endogenous FIP200 protein in glioblastoma tumor cells, astrocytes, and brain MvECs promotes apoptosis, most likely due to the removal of a direct interaction of FIP200 with Pyk2 that inhibits Pyk2 activation, suggesting that FIP200 expression may be required for the survival of all three cell types found in glioblastoma tumors.
FIP200 在正常脑组织中的表达局限于某些神经元和神经胶质细胞。在对胶质母细胞瘤肿瘤活检组织进行免疫组化分析时,我们在肿瘤细胞、肿瘤相关的内皮细胞和偶尔的神经胶质细胞中检测到了 FIP200。人胶质母细胞瘤肿瘤细胞系和在完全培养基中培养的永生化人星形胶质细胞以及原代人脑微血管内皮细胞(MvEC)也表达了 FIP200,而 MvEC 在培养中增殖并类似于反应性内皮细胞。使用小干扰 RNA 下调内源性 FIP200 的表达会导致人胶质母细胞瘤肿瘤细胞、永生化人星形胶质细胞和原代人脑 MvEC 发生细胞凋亡。其他研究人员使用来自其他组织的细胞表明,FIP200 可以直接与富含脯氨酸的酪氨酸激酶 2(Pyk2)和粘着斑激酶(FAK)相互作用并抑制其活性。在人胶质母细胞瘤肿瘤细胞、永生化人星形胶质细胞和原代人脑 MvEC 中,我们发现下调 FIP200 会增加 Pyk2 的活性而不增加其表达,但不会影响 FAK 的活性或表达。共免疫沉淀和共定位研究表明,在胶质母细胞瘤肿瘤细胞和脑 MvEC 中,内源性 FIP200 主要与 Pyk2 而不是 FAK 相关。此外,在这些细胞中,含有 Pyk2 自身磷酸化位点的 TAT-Pyk2 融合蛋白可显著抑制 FIP200 下调的促凋亡作用。总之,下调胶质母细胞瘤肿瘤细胞、星形胶质细胞和脑 MvEC 中的内源性 FIP200 蛋白会促进细胞凋亡,这很可能是由于 FIP200 与 Pyk2 的直接相互作用被去除,从而抑制了 Pyk2 的激活,这表明 FIP200 的表达可能是所有三种在胶质母细胞瘤肿瘤中发现的细胞类型存活所必需的。